Sign in
Taking peopleNo phase

Early WAKE-up Predictors After Out-of-Hospital Cardiac Arrest

Key facts

Who runs it
University of Aarhus
Where
Denmark2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
250 people, planned
Started
13 May 2025
Expected to end
Dec 2027
Type of study
Observational
Treatments tested
  • Automated Pupillometry
  • Transcranial Doppler Ultrasound
  • Optic Nerve Sheath Diameter
  • Continuous EEG and EEG Reactivity
Record updated
18 November 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 22 criteriaShow less

Who can take part

  • Age ≥18 years
  • OHCA of presumed cardiac cause
  • Sustained ROSC, defined as persistent signs of circulation and no need for chest compressions or mechanical circulatory support for 20 minutes
  • Unconsciousness (GCS <9) (patients not able to obey verbal commands) after sustained ROSC at the time of randomization

Who cannot take part

  • Known limitations in therapy and Do Not Resuscitate-order
  • Systolic blood pressure <80 mm Hg despite fluid loading/vasopressor and/or inotropic medication (If the systolic blood pressure is recovering during the inclusion window of 180 minutes the patient may be included)
  • Ongoing (within 48 h) treatment with olanzapine or dexamethasone
  • Known bleeding diathesis (medically induced coagulopathy (e.g. warfarin, NOAC, clopidogrel) does not exclude the patient)
  • Suspected or confirmed acute intracranial bleeding
  • Suspected or confirmed acute stroke
  • Known disease making 180 days survival unlikely
  • Known allergy for dexamethasone or olanzapine
  • Known back or hip condition that precluded the patients from being positioned with backrest from 0 to 45-degree angle
  • Known active fungal disease. Localized skin lesions do not exclude patients from inclusion
  • Known or suspected Long QT Syndrome (LQTS)
  • Females of childbearing potential if pregnancy is suspected (unless a negative HCG test can rule out pregnancy within the inclusion window)
  • Unwitnessed asystole
  • Known pre-arrest CPC 3 or 4 functional status
  • >3 hours (180 minutes) from ROSC to screening
  • Use of intra-aortic balloon pump/axial flow device/ECMO (If the patient is weaned and the device is removed during the inclusion window of 180 minutes the patient may be included)
  • Temperature on admission <30°C
  • Estimated body weight <45kg

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

WAKE-OHCA is a prospective observational substudy of the Danish Out-of-Hospital Cardiac Arrest (DANOHCA) trial, identifier NCT05895838. The aim is to collect early neuromonitoring data to identify key predictors of successful wake-up.

Treatments tested

  • Automated Pupillometry
  • Transcranial Doppler Ultrasound
  • Optic Nerve Sheath Diameter
  • Continuous EEG and EEG Reactivity

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Early Wake-up Predictors After Out-of-hospital Cardiac Arrest - an Observational, Multicenter Substudy of the DANOHCA Trial
Record updated
18 November 2025